Niva Bupa Health Insurance Company Limited (IN:NIVABUPA)
:NIVABUPA
Want to see IN:NIVABUPA full AI Analyst Report?
NIVABUPA Stock Chart & Stats
₹75.96
₹1.46(1.85%)
At close: 4:00 PM EST
₹75.96
₹1.46(1.85%)
Day’s Range― - ―
52-Week Range₹67.50 - ₹94.00
Previous CloseN/A
Volume200.55K
Average Volume (3M)100.36K
Market Cap
₹158.81B
Enterprise Value₹159.78B
Total Cash (Recent Filing)₹13.08B
Total Debt (Recent Filing)₹2.50B
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,847,456,800
10 Day Avg. Volume100,838
30 Day Avg. Volume100,362
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹95.00Price Target Upside25.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.61
Revenue Forecast (FY)₹93.56B
Bulls Say, Bears Say
Bulls Say
Strong Revenue ExpansionA ~237% top-line jump in FY2026 with improved gross margin indicates meaningful premium growth and stronger underwriting scale. This enlarges the premium base, supports fixed-cost absorption and creates durable runway for improving operating leverage and distribution reach over several quarters.
Conservative Financial LeverageVery low debt-to-equity gives the insurer financial flexibility to absorb claim volatility and meet regulatory capital needs without reliance on external financing. For an insurer, this conservatism materially reduces solvency and liquidity risk over a medium-term horizon.
Positive Free Cash Flow And Earnings ConversionConsistent positive FCF with close alignment to reported earnings signals high earnings quality and solid cash conversion. Sustained cash generation supports reserve funding, claims payments and selective reinvestment or capital allocation, underpinning durable operational resilience.
Bears Say
Material Margin CompressionA sharp decline in operating and net margins indicates rising claims, higher operating costs or weaker pricing power. If these pressures persist, they materially erode the insurer's ability to build capital, reduce underwriting profitability and constrain sustainable return generation over the next several quarters.
Modest Return On EquityLow ROE signals limited efficiency in converting equity into profitable growth. Persistently modest returns restrict internal capital formation, may force external capital needs for expansion, and cap shareholder value creation over a medium-term investment horizon.
Declining Cash Generation Year-over-yearA roughly halved FCF versus the prior year reduces the company's cash cushion for reserves, claims volatility and strategic initiatives. Continued declines in cash generation would weaken reinvestment capacity and increase execution risk for maintaining underwriting standards and growth.
Niva Bupa Health Insurance Company Limited News
NIVABUPA FAQ
What was Niva Bupa Health Insurance Company Limited’s price range in the past 12 months?
Niva Bupa Health Insurance Company Limited lowest stock price was ₹67.50 and its highest was ₹94.00 in the past 12 months.
What is Niva Bupa Health Insurance Company Limited’s market cap?
Niva Bupa Health Insurance Company Limited’s market cap is ₹158.81B.
When is Niva Bupa Health Insurance Company Limited’s upcoming earnings report date?
Niva Bupa Health Insurance Company Limited’s upcoming earnings report date is Jul 30, 2026 which is in 67 days.
How were Niva Bupa Health Insurance Company Limited’s earnings last quarter?
Niva Bupa Health Insurance Company Limited released its earnings results on May 08, 2026. The company reported ₹1.885 earnings per share for the quarter, beating the consensus estimate of ₹1.45 by ₹0.435.
Is Niva Bupa Health Insurance Company Limited overvalued?
According to Wall Street analysts Niva Bupa Health Insurance Company Limited’s price is currently Undervalued.
Does Niva Bupa Health Insurance Company Limited pay dividends?
Niva Bupa Health Insurance Company Limited does not currently pay dividends.
What is Niva Bupa Health Insurance Company Limited’s EPS estimate?
Niva Bupa Health Insurance Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Niva Bupa Health Insurance Company Limited have?
Niva Bupa Health Insurance Company Limited has 1,847,456,800 shares outstanding.
What happened to Niva Bupa Health Insurance Company Limited’s price movement after its last earnings report?
Niva Bupa Health Insurance Company Limited reported an EPS of ₹1.885 in its last earnings report, beating expectations of ₹1.45. Following the earnings report the stock price went up 1.524%.
Which hedge fund is a major shareholder of Niva Bupa Health Insurance Company Limited?
Currently, no hedge funds are holding shares in IN:NIVABUPA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited is a subsidiary of Bupa Singapore Holdings Pte. Ltd.
NIVABUPA Stock 12 Month Forecast
Average Price Target
₹95.00
▲(25.07% Upside)
Technical Analysis
HDFC Life Insurance Co. Ltd.
―
ICICI Prudential Life Insurance Co. Ltd.
―
Max Financial Services Limited
―
SBI Life Insurance Co. Ltd.
―
Star Health & Allied Insurance Co. Ltd.
―